HCA Healthcare Inc

HCA Healthcare Inc Stock Forecast & Price Prediction

Live HCA Healthcare Inc Stock (HCA) Price
$348.75

22

Ratings

  • Buy 16
  • Hold 6
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$348.75

P/E Ratio

16.47

Volume Traded Today

$3.4M

Dividend

$0.66

52 Week High/low

417.14/226.48

HCA Healthcare Inc Market Cap

$92.87B

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $HCA ๐Ÿ›‘

Before you buy HCA you'll want to see this list of ten stocks that have huge potential. Want to see if HCA made the cut? Enter your email below

HCA Summary

The HCA Healthcare Inc (HCA) share price is expected to increase by 17.97% over the next year. This is based on calculating the average 12-month share price estimate provided by 22 stock analysts who have covered HCA. Price targets range from $359 at the low end to $460 at the high end. The current analyst consensus for HCA is a buy. Please note analyst price targets are not guaranteed and could be missed completely.

HCA Analyst Ratings

HCA is a stock in Healthcare which has been forecasted to be worth $411.41 as an average. On the higher end, the forecast price is $460 USD by from and on the lower end HCA is forecasted to be $359 by Pito Chickering from Deutsche Bank.

HCA stock forecast by analyst

These are the latest 20 analyst ratings of HCA.

Analyst/Firm

Rating

Price Target

Change

Date

Stephen Baxter
Wells Fargo

Equal-Weight

$400

Maintains

Nov 6, 2024
Michael Wiederhorn
Oppenheimer

Outperform

$400

Maintains

Oct 28, 2024
Gary Taylor
TD Cowen

Buy

$440

Maintains

Oct 28, 2024
Matthew Gillmor
Keybanc

Overweight

$420

Maintains

Oct 28, 2024
Stephen Baxter
Wells Fargo

Equal-Weight

$395

Maintains

Oct 22, 2024
Matthew Gillmor
Keybanc

Overweight

$475

Initiates

Oct 11, 2024
Sarah James
Cantor Fitzgerald

Overweight

$392

Reiterates

Oct 4, 2024
Sarah James
Cantor Fitzgerald

Overweight

$392

Reiterates

Oct 1, 2024
Craig Hettenbach
Morgan Stanley

Equal-Weight

$427

Initiates

Sep 3, 2024
Ben Hendrix
RBC Capital

Outperform

$405

Maintains

Aug 23, 2024
Sarah James
Cantor Fitzgerald

Overweight

$392

Reiterates

Aug 20, 2024
David Macdonald
Truist Securities

Buy

$430

Maintains

Aug 19, 2024
Sarah James
Cantor Fitzgerald

Overweight

$392

Reiterates

Aug 19, 2024
Andrew Mok
UBS

Buy

$438

Maintains

Aug 14, 2024
Stephen Baxter
Wells Fargo

Equal-Weight

$365

Maintains

Jul 30, 2024
Sarah James
Cantor Fitzgerald

Overweight

$392

Maintains

Jul 25, 2024
Andrew Mok
Barclays

Overweight

$396

Maintains

Jul 24, 2024
Michael Wiederhorn
Oppenheimer

Outperform

$390

Maintains

Jul 24, 2024

Leerink Partners

Outperform

$396

Maintains

Jul 24, 2024
Sarah James
Cantor Fitzgerald

Overweight

$335

Reiterates

Jul 24, 2024

HCA Company Information

What They Do: Operates hospitals and healthcare facilities in the U.S.

Business Model: The company generates revenue primarily through the provision of a wide range of medical services, including inpatient and outpatient care, surgical procedures, and specialized treatments across its various healthcare facilities. HCA Healthcare's diversified offerings allow it to cater to different patient needs, from emergency services to long-term rehabilitation, thereby capturing a broad market segment.

Other Information: Founded in 1968 and headquartered in Nashville, Tennessee, HCA Healthcare operates numerous facilities, including general hospitals, outpatient centers, and behavioral health institutions. The company has a strong presence in the U.S. healthcare industry, positioning itself as a key player in providing comprehensive healthcare solutions.
HCA
HCA Healthcare Inc (HCA)

When did it IPO

2011

Staff Count

220,000

Country

United States

Sector/Industry

Healthcare/Medical Care Facilities

CEO

Mr. Samuel N. Hazen

Market Cap

$92.87B

HCA Healthcare Inc (HCA) Financial Data

In 2023, HCA generated $64.97B in revenue, which was a increase of 7.86% from the previous year. This can be seen as a signal that HCA's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$51.53B

Revenue From 2021

$58.75B

14.01 %
From Previous Year

Revenue From 2022

$60.23B

2.52 %
From Previous Year

Revenue From 2023

$64.97B

7.86 %
From Previous Year
  • Revenue TTM $69.62B
  • Operating Margin TTM 13.8%
  • Gross profit TTM $55.07B
  • Return on assets TTM 11.5%
  • Return on equity TTM 1,195.5%
  • Profit Margin 8.5%
  • Book Value Per Share -8.57%
  • Market capitalisation $92.87B
  • Revenue for 2021 $58.75B
  • Revenue for 2022 $60.23B
  • Revenue for 2023 $64.97B
  • EPS this year (TTM) $21.17

HCA Healthcare Inc (HCA) Latest News

News Image

Wed, 06 Nov 2024

Sentiment - NEGATIVE

Source - Market Watch

Summary - Investors express concern over potential impacts on hospital operators and vaccine makers under a Trump administration, while showing optimism for Medicare Advantage plan providers.

Why It Matters - Concerns over regulatory shifts under a Trump administration could impact hospital operators and vaccine makers, while optimism for Medicare Advantage plans suggests potential growth in that sector.

News Image

Sat, 02 Nov 2024

Sentiment - POSITIVE

Source - MarketBeat

Summary - HCA Healthcare (NYSE: HCA), the third-largest U.S. healthcare provider, has seen its shares decline over 13% since reaching an all-time high on October 18.

Why It Matters - HCA's recent 13% drop from its all-time high may indicate volatility in the healthcare sector, potentially affecting investor sentiment and future performance outlook.

News Image

Wed, 30 Oct 2024

Sentiment - POSITIVE

Source - Zacks Investment Research

Summary - HCA is expected to gain from increased volume growth and ongoing expansion initiatives.

Why It Matters - HCA's anticipated volume growth and expansion could lead to increased revenues and market share, positively impacting its stock performance and overall financial health.

News Image

Fri, 25 Oct 2024

Sentiment - POSITIVE

Source - Reuters

Summary - HCA Healthcare surpassed Wall Street profit estimates due to higher hospital admissions and lower labor costs in the latest quarterly results.

Why It Matters - HCA Healthcareโ€™s earnings beat signals strong operational efficiency and demand, potentially boosting investor confidence and stock performance in the healthcare sector.

News Image

Fri, 25 Oct 2024

Sentiment - NEGATIVE

Source - Investopedia

Summary - HCA Healthcare (HCA) announced that recent hurricanes will negatively affect its results, leading to a roughly 10% decline in shares on Friday afternoon.

Why It Matters - HCA Healthcare's forecasted losses from recent hurricanes indicate potential revenue declines, leading to a significant share price drop, which affects investor confidence and portfolio performance.

News Image

Fri, 25 Oct 2024

Sentiment - NEGATIVE

Source - Investors Business Daily

Summary - HCA stock fell after missing Q3 estimates, attributing the shortfall to hurricanes and providing a subdued outlook, raising concerns for investors.

Why It Matters - HCA's Q3 miss signals operational challenges and potential ongoing impacts from external factors, raising concerns about future performance and profitability, which can affect stock value.

...

HCA Frequently asked questions

The highest forecasted price for HCA is $460 from at .

The lowest forecasted price for HCA is $359 from Pito Chickering from Deutsche Bank

The HCA analyst ratings consensus are 16 buy ratings, 6 hold ratings, and 0 sell ratings.